Viewing Study NCT00829894


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-25 @ 11:39 PM
Study NCT ID: NCT00829894
Status: COMPLETED
Last Update Posted: 2024-08-19
First Post: 2009-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions
Sponsor: Teva Pharmaceuticals USA
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-06
Start Date Type: None
Primary Completion Date: 2001-07
Primary Completion Date Type: ACTUAL
Completion Date: 2001-07
Completion Date Type: ACTUAL
First Submit Date: 2009-01-26
First Submit QC Date: None
Study First Post Date: 2009-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-15
Last Update Post Date: 2024-08-19
Last Update Post Date Type: ACTUAL